Richard Daniell
Executive Vice President, European Commercial
Richard Daniell became Executive Vice President, European Commercial in November 2017, leading all activities of Teva Europe’s Generic, Specialty and over the counter (OTC) businesses as well as our Teva API and Medis B2B units.
With headquarters in The Netherlands, Teva Europe employs approximately 19,000 people in the region and covers 36 countries. Teva is Europe’s biggest provider of tried-and-trusted generic medicine, a leading provider of OTC medicines and a recognized innovator in CNS, respiratory medicines and biopharmaceuticals.
Before assuming this responsibility, Richard headed up Teva Europe Generics. Prior to that he served as Chief Operating Officer of International Markets and led the integration of the Actavis Generics business into Teva globally. Before that he served as General Manager for the United Kingdom and Ireland.
Richard received his B.Sc. degree in chemistry from the University of Auckland, New Zealand.
Richard Francis
President and Chief Executive Officer, Member of the Board of Directors
Dr. Sven Dethlefs
Executive Vice President, North America Commercial
Eric Drapé
Executive Vice President, Global Operations
Angus J. Grant, PhD
Executive Vice President, Business Development
Dr. Eric A. Hughes
Executive Vice President, Global R&D and Chief Medical Officer
Galia Inbar
Executive Vice President, Chief Human Resources Officer and Corporate Affairs
Eli Kalif
Executive Vice President, Chief Financial Officer (CFO)
Mark Sabag
Executive Vice President, International Markets Commercial
David M. Stark
Executive Vice President, Chief Legal Officer
Nir Baron
Senior Vice President, Chief Internal Auditor
Kathleen Veit
Senior Vice President, Global Compliance & Ethics Officer
